III

Antibody Engineering of Drugs to New Treatments

  • Chair(s):

    Ahuva Nissim,
    Prof in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom

  • Session description:

    Targeting Drugs by Diseased Tissue Specific Antibody
    Professor Ahuva Nissim
    Proessorf in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom

    Subcellular Trafficking Pathways as Targets for the Design of Therapies for Autoimmunity and Cancer
    Professor Sally Ward
    Professor of Molecular Immunology and Director of Translational Immunology, University of Southampton, Southampton, United Kingdom

    Oral communication speaker - to be confirmed in 2022.

    Amplifying Antibody Diversity: Single-Cell Screening Combined with Repertoire Sequencing from Humanized Mice
    Dr Kevin Heyries
    AbCellara Biologics, Vancouver, Canada

    Twist Bioscience anti-SARS-CoV-2 antibodies
    Dr Licy Xu
    Twist Bioscience, San Francisco, The United States of America

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

04 Jul 2023

Time

4:05 pm - 6:30 pm

Speakers

Leave A Comment